Ikerian AG and its subsidiary RetinAI have launched RetinAI Discovery for Clinics, a software solution designed to improve treatment workflows, referrals and patient management decisions for eye care providers.
“Discovery for Clinics is a powerful tool empowering not only physicians with enhanced AI-powered data insights to optimize outcomes and treatments, but also patients, giving them access to their data,” Carlos Ciller, PhD, CEO and co-founder of Ikerian, said in a company press release.
According to the release, the vendor-neutral platform collects large datasets in a